Download presentation
Presentation is loading. Please wait.
Published byBohumír Bezucha Modified over 5 years ago
1
Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients D. He, S. Guo, P. Zhu, S. Tao, M. Li, H. Huang, J. Wang, Y. Wang, M. Ding Clinical Microbiology and Infection Volume 20, Issue 10, Pages O687-O693 (October 2014) DOI: / Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions
2
FIG. 1 Survival functions for the cumulative rate of sustained response and the time of sustained response after NUC discontinuation. The cumulative rate of sustained response was 91.8% (a). No significant difference in the cumulative rate of sustained response was observed for sex (b, p = 0.620), age (c, p = 0.061), baseline ALT (d, p = 0.632), NUCs (e, p = 0.760) or genotype (f, p = 0.202). Clinical Microbiology and Infection , O687-O693DOI: ( / ) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.